Mohamad Anas Abou-Shamat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohamad Anas Abou-Shamat has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Michael Thomas Cook
UCL School of Pharmacy, University College London, London, WC1N 1AX, UK
3 shared publications - Jesus Calvo-Castro
School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK
2 shared publications I. Salah
Department of Clinical and Pharmaceutical Sciences Centre for Research in Topical Drug Delivery and Toxicology, University of Hertfordshire Hatfield, Hertfordshire AL10 9AB UK
1 shared publicationJacqueline Leslie Stair
School of Life and Medical Sciences, University of Hertfordshire, UK
1 shared publication- Jacqueline Leslie Stair
Department of Pharmacy
1 shared publication - Stewart Brian Kirton
Department of Clinical Pharmaceutical and Biological Science, University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL10 9AB, United Kingdom
1 shared publication
Latest Publications
- 13 October 2020
- Published by Royal Society of Chemistry (RSC) in Molecular Systems Design & Engineering
- Vol. 5 (9) , 1538-1546
A Design-of-Experiments approach to developing thermoresponsive gelators from complex polymer mixtures
This study investigated the effects of additives on the properties of poloxamer (P) 407 thermogels, employing a Design-of-Experiments (DoE) approach.
- 13 October 2020
- Published by Royal Society of Chemistry (RSC) in Molecular Systems Design & Engineering
- Vol. 5 (9) , 1538-1546
A Design-of-Experiments approach to developing thermoresponsive gelators from complex polymer mixtures
This study investigated the effects of additives on the properties of poloxamer (P) 407 thermogels, employing a Design-of-Experiments (DoE) approach.
- 22 July 2019
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 220 (16) , 1900173
Modifying the Properties of Thermogelling Poloxamer 407 Solutions through Covalent Modification and the Use of Polymer Additives
Thermoresponsive polymers that undergo sol–gel transition in a physiological temperature range have applications in biomedical science. Poloxamer 407 (P407) is commonly used as thermogelling material and has been approved by the Food and Drug Administration (FDA) in licenced medicines. However, it has significant drawbacks which limit its performance, particularly in drug delivery systems. In order to improve these properties, the chemical structure of P407 has been modified to produce stronger gels by either conjugating P407 with other polymers or introducing inter‐micelle linkers to the terminal hydroxyl groups of P407. However, chemical modifications have several undesirable side‐effects. The change in the chemical structure makes the polymer a novel excipient, and additional safety risks are possible, requiring expensive and time‐consuming toxicity testing prior to regulatory approval. An alternative approach to covalent modification is modifying the P407 formulations with additives including hydrophilic polymers and nanoparticles, in an attempt to improve the properties of these materials. This review investigates the approaches used to modify the properties of P407 thermogelling materials, including the use of polymer additives and covalent modification. Several recommendations are made, based on efficacy and consideration of regulatory risk to guide the development of these materials toward use in real clinical applications.
- 22 July 2019
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 220 (16) , 1900173
Modifying the Properties of Thermogelling Poloxamer 407 Solutions through Covalent Modification and the Use of Polymer Additives
Thermoresponsive polymers that undergo sol–gel transition in a physiological temperature range have applications in biomedical science. Poloxamer 407 (P407) is commonly used as thermogelling material and has been approved by the Food and Drug Administration (FDA) in licenced medicines. However, it has significant drawbacks which limit its performance, particularly in drug delivery systems. In order to improve these properties, the chemical structure of P407 has been modified to produce stronger gels by either conjugating P407 with other polymers or introducing inter‐micelle linkers to the terminal hydroxyl groups of P407. However, chemical modifications have several undesirable side‐effects. The change in the chemical structure makes the polymer a novel excipient, and additional safety risks are possible, requiring expensive and time‐consuming toxicity testing prior to regulatory approval. An alternative approach to covalent modification is modifying the P407 formulations with additives including hydrophilic polymers and nanoparticles, in an attempt to improve the properties of these materials. This review investigates the approaches used to modify the properties of P407 thermogelling materials, including the use of polymer additives and covalent modification. Several recommendations are made, based on efficacy and consideration of regulatory risk to guide the development of these materials toward use in real clinical applications.
- 12 September 2018
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 136 (1)
Soluplus solutions as thermothickening materials for topical drug delivery
Soluplus is a pharmaceutical excipient used primarily in the manufacture of solid dispersions. The polymer also exhibits interesting rheology in aqueous solution, increasing in viscosity as the solution is warmed. This material could have application topical drug delivery to sites including the skin, vagina, rectum or nasal mucosa, where the increase in viscosity allows for improved retention. However, there exists very little information surrounding this “thermothickening” phenomenon and the effect of solution composition on temperature‐dependent rheology. In this study, the effect of soluplus concentration, salt inclusion, ethanol addition, and pH on temperature‐dependent rheology was measured. The rheology of the solutions was unaffected by pH over the range tolerated by the skin (pH 4–7), but the inclusion of ethanol rapidly negated the thermothickening effect. “Salting out” of the solutions resulted in a depression of gelation temperatures, and an increase in both storage and loss moduli of the solutions. 30% (w/v) soluplus in 1 M NaCl or KCl was identified as a potential thermothickening agent for topical drug delivery. © 2018 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2019, 136, 46915.
- 12 September 2018
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 136 (1)
Soluplus solutions as thermothickening materials for topical drug delivery
Soluplus is a pharmaceutical excipient used primarily in the manufacture of solid dispersions. The polymer also exhibits interesting rheology in aqueous solution, increasing in viscosity as the solution is warmed. This material could have application topical drug delivery to sites including the skin, vagina, rectum or nasal mucosa, where the increase in viscosity allows for improved retention. However, there exists very little information surrounding this “thermothickening” phenomenon and the effect of solution composition on temperature‐dependent rheology. In this study, the effect of soluplus concentration, salt inclusion, ethanol addition, and pH on temperature‐dependent rheology was measured. The rheology of the solutions was unaffected by pH over the range tolerated by the skin (pH 4–7), but the inclusion of ethanol rapidly negated the thermothickening effect. “Salting out” of the solutions resulted in a depression of gelation temperatures, and an increase in both storage and loss moduli of the solutions. 30% (w/v) soluplus in 1 M NaCl or KCl was identified as a potential thermothickening agent for topical drug delivery. © 2018 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2019, 136, 46915.